Last reviewed: July 14, 2026 Last updated: July 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Researchers attribute this rise in exposures to increases in prescriptions for these medications and an increase in therapeutic errors
Black and brown patients also have limited access to medical information, and may face incorrect assumptions and biases when they enter a medical office (particularly if the provider does not share their lived experience), Dr
In laboratory settings, this compound is studied for its involvement in cellular processes related to tissue environments, structural protein activity, and model systems examining regenerative pathways
A.StrowigS